Exact Mass: 334.1529
Exact Mass Matches: 334.1529
Found 164 metabolites which its exact mass value is equals to given mass value 334.1529,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
9-Fluoro-16alpha-hydroxyandrost-4-ene-3,11,17-trione
9-Fluoro-16alpha-hydroxyandrost-4-ene-3,11,17-trione
3'-N'-Acetylfusarochromanone
N-[4-(5-Amino-2,2-dimethyl-4-oxo-3,4-dihydro-2H-1-benzopyran-6-yl)-1-hydroxy-4-oxobutan-2-yl]ethanimidate
3-N-Acetylfusarochromanone is a mycotoxin produced by Fusarium equiseti. Mycotoxin production by Fusarium equiseti
1,5-Dibutyl methyl hydroxycitrate
1,3-Dibutyl 2-methyl 1,2-dihydroxypropane-1,2,3-tricarboxylic acid
1,5-Dibutyl methyl hydroxycitrate is found in fruits. 1,5-Dibutyl methyl hydroxycitrate is a constituent of the fruit of Garcinia atroviridis (gelugor). Constituent of the fruit of Garcinia atroviridis (gelugor). 1,5-Dibutyl methyl hydroxycitrate is found in fruits.
Amifloxacin
6-fluoro-1-(methylamino)-7-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
Amifloxacin belongs to the family of Phenylpiperazines. These are compounds containing a phenylpiperazine skeleton, which consists of a piperazine bound to a phenyl group. D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D004791 - Enzyme Inhibitors
DL-Methionine-4-antipyrineamide
2-amino-N-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-4-(methylsulfanyl)butanamide
(E)-5-(1-(2-Hydroxyethyl)-3-(pyridin-4-yl)-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime
2-{4-[1-(hydroxyimino)-2,3-dihydro-1H-inden-5-yl]-3-(pyridin-4-yl)-1H-pyrazol-1-yl}ethan-1-ol
Pimobendan
4,5-dihydro-6-(2-(4-Methoxyphenyl)-1H-benzimidazole-5-yl)-5-methyl-3(2H)-pyridazinone
D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor D020011 - Protective Agents > D002316 - Cardiotonic Agents
3-O-Alloside-Cerberidol-Cerberidol|cerberidol-3-O-beta-D-allopyranoside
3-O-Alloside-Cerberidol-Cerberidol|cerberidol-3-O-beta-D-allopyranoside
C19H26O3S_2-Propenoic acid, 3-(methylthio)-, (1R,2R,8aR)-1,2,3,4,6,7,8,8a-octahydro-1,8a-dimethyl-7-(1-methylethylidene)-6-oxo-2-naphthalenyl ester, (2E)
NCGC00384919-01_C19H26O3S_2-Propenoic acid, 3-(methylthio)-, (1R,2R,8aR)-1,2,3,4,6,7,8,8a-octahydro-1,8a-dimethyl-7-(1-methylethylidene)-6-oxo-2-naphthalenyl ester, (2E)-
Ala Ala Ser Ser
(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]propanamido]-3-hydroxypropanamido]-3-hydroxypropanoic acid
Ala Gly Ser Thr
(2S,3R)-2-[(2S)-2-{2-[(2S)-2-aminopropanamido]acetamido}-3-hydroxypropanamido]-3-hydroxybutanoic acid
Ala Gly Thr Ser
(2S)-2-[(2S,3R)-2-{2-[(2S)-2-aminopropanamido]acetamido}-3-hydroxybutanamido]-3-hydroxypropanoic acid
Ala Ser Ala Ser
(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-hydroxypropanamido]propanamido]-3-hydroxypropanoic acid
Ala Ser Gly Thr
(2S,3R)-2-{2-[(2S)-2-[(2S)-2-aminopropanamido]-3-hydroxypropanamido]acetamido}-3-hydroxybutanoic acid
Ala Ser Ser Ala
(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-hydroxypropanamido]-3-hydroxypropanamido]propanoic acid
Ala Ser Thr Gly
2-[(2S,3R)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-hydroxypropanamido]-3-hydroxybutanamido]acetic acid
Ala Thr Gly Ser
(2S)-2-{2-[(2S,3R)-2-[(2S)-2-aminopropanamido]-3-hydroxybutanamido]acetamido}-3-hydroxypropanoic acid
Ala Thr Ser Gly
2-[(2S)-2-[(2S,3R)-2-[(2S)-2-aminopropanamido]-3-hydroxybutanamido]-3-hydroxypropanamido]acetic acid
Gly Ala Ser Thr
(2S,3R)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)propanamido]-3-hydroxypropanamido]-3-hydroxybutanoic acid
Gly Ala Thr Ser
(2S)-2-[(2S,3R)-2-[(2S)-2-(2-aminoacetamido)propanamido]-3-hydroxybutanamido]-3-hydroxypropanoic acid
Gly Gly Thr Thr
(2S,3R)-2-[(2S,3R)-2-[2-(2-aminoacetamido)acetamido]-3-hydroxybutanamido]-3-hydroxybutanoic acid
Gly Ser Ala Thr
(2S,3R)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]propanamido]-3-hydroxybutanoic acid
Gly Ser Thr Ala
(2S)-2-[(2S,3R)-2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]-3-hydroxybutanamido]propanoic acid
Gly Thr Ala Ser
(2S)-2-[(2S)-2-[(2S,3R)-2-(2-aminoacetamido)-3-hydroxybutanamido]propanamido]-3-hydroxypropanoic acid
Gly Thr Gly Thr
(2S,3R)-2-{2-[(2S,3R)-2-(2-aminoacetamido)-3-hydroxybutanamido]acetamido}-3-hydroxybutanoic acid
Gly Thr Ser Ala
(2S)-2-[(2S)-2-[(2S,3R)-2-(2-aminoacetamido)-3-hydroxybutanamido]-3-hydroxypropanamido]propanoic acid
Gly Thr Thr Gly
2-[(2S,3R)-2-[(2S,3R)-2-(2-aminoacetamido)-3-hydroxybutanamido]-3-hydroxybutanamido]acetic acid
Ser Ala Ala Ser
(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]propanamido]propanamido]-3-hydroxypropanoic acid
Ser Ala Gly Thr
(2S,3R)-2-{2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]propanamido]acetamido}-3-hydroxybutanoic acid
Ser Ala Ser Ala
(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]propanamido]-3-hydroxypropanamido]propanoic acid
Ser Ala Thr Gly
2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]propanamido]-3-hydroxybutanamido]acetic acid
Ser Gly Ala Thr
(2S,3R)-2-[(2S)-2-{2-[(2S)-2-amino-3-hydroxypropanamido]acetamido}propanamido]-3-hydroxybutanoic acid
Ser Gly Thr Ala
(2S)-2-[(2S,3R)-2-{2-[(2S)-2-amino-3-hydroxypropanamido]acetamido}-3-hydroxybutanamido]propanoic acid
Ser Ser Ala Ala
(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxypropanamido]propanamido]propanoic acid
Ser Thr Ala Gly
2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxybutanamido]propanamido]acetic acid
Ser Thr Gly Ala
(2S)-2-{2-[(2S,3R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxybutanamido]acetamido}propanoic acid
Thr Ala Gly Ser
(2S)-2-{2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]propanamido]acetamido}-3-hydroxypropanoic acid
Thr Ala Ser Gly
2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]propanamido]-3-hydroxypropanamido]acetic acid
Thr Gly Ala Ser
(2S)-2-[(2S)-2-{2-[(2S,3R)-2-amino-3-hydroxybutanamido]acetamido}propanamido]-3-hydroxypropanoic acid
Thr Gly Gly Thr
(2S,3R)-2-(2-{2-[(2S,3R)-2-amino-3-hydroxybutanamido]acetamido}acetamido)-3-hydroxybutanoic acid
Thr Gly Ser Ala
(2S)-2-[(2S)-2-{2-[(2S,3R)-2-amino-3-hydroxybutanamido]acetamido}-3-hydroxypropanamido]propanoic acid
Thr Gly Thr Gly
2-[(2S,3R)-2-{2-[(2S,3R)-2-amino-3-hydroxybutanamido]acetamido}-3-hydroxybutanamido]acetic acid
Thr Ser Ala Gly
2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxypropanamido]propanamido]acetic acid
Thr Ser Gly Ala
(2S)-2-{2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxypropanamido]acetamido}propanoic acid
Thr Thr Gly Gly
2-{2-[(2S,3R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxybutanamido]acetamido}acetic acid
TDP 2
N-[4-(5-amino-2,2-dimethyl-4-oxo-3,4-dihydro-2H-1-benzopyran-6-yl)-1-hydroxy-4-oxobutan-2-yl]acetamide
amifloxacin
6-fluoro-1-(methylamino)-7-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D004791 - Enzyme Inhibitors
(2E,6E)-2,6-bis[(3-methoxyphenyl)methylidene]cyclohexan-1-one
(2E,6E)-2,6-bis[(3-methoxyphenyl)methylidene]cyclohexan-1-one
(3-acryloxypropyl)methylbis(trimethylsiloxy)silane
(3-acryloxypropyl)methylbis(trimethylsiloxy)silane
4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid ethyl ester
4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid ethyl ester
(S)-2-((TERT-BUTOXYCARBONYL)AMINO)-3-(5-METHOXY-1H-INDOL-3-YL)PROPANOIC ACID
(S)-2-((TERT-BUTOXYCARBONYL)AMINO)-3-(5-METHOXY-1H-INDOL-3-YL)PROPANOIC ACID
(S)-(3-N-BOC-AMINO-2-OXO-2,3,4,5-TETRAHYDRO-BENZO[B]AZEPIN-1-YL)-ACETIC ACID
(S)-(3-N-BOC-AMINO-2-OXO-2,3,4,5-TETRAHYDRO-BENZO[B]AZEPIN-1-YL)-ACETIC ACID
GDC-0879
(E)-5-(1-(2-Hydroxyethyl)-3-(pyridin-4-yl)-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime
GDC-0879 is a potent and selective B-Raf inhibitor with an IC50 of 0.13 nM.
tert-butyl (4S)-3-(benzyloxycarbonyl)-1-methyl-2-oxoimidazolidine-4-carboxylate
tert-butyl (4S)-3-(benzyloxycarbonyl)-1-methyl-2-oxoimidazolidine-4-carboxylate
(s)-boc-4-amino-2-carboxymethyl-1,3,4,5-tetrahydro-2h-[2]-benzazepin-3-one
(s)-boc-4-amino-2-carboxymethyl-1,3,4,5-tetrahydro-2h-[2]-benzazepin-3-one
(2R,5S)-rel-Tetrahydro-5-propyl-2-(3,4,5-trifluoro[1,1-biphenyl]-4-yl)-2H-pyran
(2R,5S)-rel-Tetrahydro-5-propyl-2-(3,4,5-trifluoro[1,1-biphenyl]-4-yl)-2H-pyran
3-(4-FLUOROPHENYL)-N-(4-(PYRIDIN-4-YLMETHYL)PHENYL)PROPANAMIDE
3-(4-FLUOROPHENYL)-N-(4-(PYRIDIN-4-YLMETHYL)PHENYL)PROPANAMIDE
2-(1-Amino-1-methylethyl)-N-(4-fluorobenzyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidine-4-carboxamide
2-(1-Amino-1-methylethyl)-N-(4-fluorobenzyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidine-4-carboxamide
10,11-Dimethoxy-4-methyldibenzo[c,f]-2,7-naphthyridine-3,6-diamine
10,11-Dimethoxy-4-methyldibenzo[c,f]-2,7-naphthyridine-3,6-diamine
4-[[2-(4-Ethyl-3-oxo-2-morpholinyl)-1-oxoethyl]amino]benzoic acid ethyl ester
4-[[2-(4-Ethyl-3-oxo-2-morpholinyl)-1-oxoethyl]amino]benzoic acid ethyl ester
N-(3,4-dimethylphenyl)-4-oxo-3,10-dihydro-2H-pyrimido[1,2-a]benzimidazole-2-carboxamide
N-(3,4-dimethylphenyl)-4-oxo-3,10-dihydro-2H-pyrimido[1,2-a]benzimidazole-2-carboxamide
(3S)-N-(5-chloro-2-methylphenyl)-1-cyclohexyl-5-oxopyrrolidine-3-carboxamide
(3S)-N-(5-chloro-2-methylphenyl)-1-cyclohexyl-5-oxopyrrolidine-3-carboxamide
(3s)-N-(3-Chloro-2-Methylphenyl)-1-Cyclohexyl-5-Oxopyrrolidine-3-Carboxamide
(3s)-N-(3-Chloro-2-Methylphenyl)-1-Cyclohexyl-5-Oxopyrrolidine-3-Carboxamide
Pimobendan
Pimobendan
D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor D020011 - Protective Agents > D002316 - Cardiotonic Agents
2-[[(2R)-2-amino-3-(4-hydroxy-1-oxononan-3-yl)sulfanylpropanoyl]amino]acetic acid
2-[[(2R)-2-amino-3-(4-hydroxy-1-oxononan-3-yl)sulfanylpropanoyl]amino]acetic acid
(1,8a-dimethyl-6-oxo-7-prop-1-en-2-yl-1,2,3,4,7,8-hexahydronaphthalen-2-yl) (E)-3-methylsulfanylprop-2-enoate
(1,8a-dimethyl-6-oxo-7-prop-1-en-2-yl-1,2,3,4,7,8-hexahydronaphthalen-2-yl) (E)-3-methylsulfanylprop-2-enoate
alpha-N-Carbobenzyloxy-epsilon-N-acryloyl-L-lysine
alpha-N-Carbobenzyloxy-epsilon-N-acryloyl-L-lysine
2-Tert-butyl-4-chloro-5-(3-methyl-5-propan-2-ylphenoxy)-3-pyridazinone
2-Tert-butyl-4-chloro-5-(3-methyl-5-propan-2-ylphenoxy)-3-pyridazinone
2-(2-Furanyl)-5-[4-(phenylmethyl)-1-piperazinyl]-4-oxazolecarbonitrile
2-(2-Furanyl)-5-[4-(phenylmethyl)-1-piperazinyl]-4-oxazolecarbonitrile
N3-(2,4-Dimethylphenyl)-N1-phenylpyrazole-1,3-dicarboxamide
N3-(2,4-Dimethylphenyl)-N1-phenylpyrazole-1,3-dicarboxamide
6-(3,5-dimethyl-4-isoxazolyl)-N-[1-(2-furanyl)ethyl]-4-quinazolinamine
6-(3,5-dimethyl-4-isoxazolyl)-N-[1-(2-furanyl)ethyl]-4-quinazolinamine
Ethyl (3E)-3-phenyl-3-(quinazolin-4-ylhydrazinylidene)propanoate
Ethyl (3E)-3-phenyl-3-(quinazolin-4-ylhydrazinylidene)propanoate
2-[(2E)-2-[1-(4-methoxyphenyl)ethylidene]hydrazinyl]-4-phenyl-1H-pyrimidin-6-one
2-[(2E)-2-[1-(4-methoxyphenyl)ethylidene]hydrazinyl]-4-phenyl-1H-pyrimidin-6-one
2-[(E)-[(8-methoxy-8-oxooctanoyl)hydrazinylidene]methyl]benzoic acid
2-[(E)-[(8-methoxy-8-oxooctanoyl)hydrazinylidene]methyl]benzoic acid
N-(cyclopropylmethyl)-2-[(2S,5R,6R)-5-(ethylsulfonylamino)-6-(hydroxymethyl)-2-oxanyl]acetamide
N-(cyclopropylmethyl)-2-[(2S,5R,6R)-5-(ethylsulfonylamino)-6-(hydroxymethyl)-2-oxanyl]acetamide
tert-Butyl 2-(allylthio)-2-(4-methoxyphenyl)pent-4-enoate
tert-Butyl 2-(allylthio)-2-(4-methoxyphenyl)pent-4-enoate
(1R,2S,4aR,4bR,7R,9aR,10S,10aR)-2-fluoro-1-methyl-8-methylidene-13-oxododecahydro-4a,1-(epoxymethano)-7,9a-methanobenzo[a]azulene-10-carboxylic acid
(1R,2S,4aR,4bR,7R,9aR,10S,10aR)-2-fluoro-1-methyl-8-methylidene-13-oxododecahydro-4a,1-(epoxymethano)-7,9a-methanobenzo[a]azulene-10-carboxylic acid
N-[(Z)-[2-(1H-imidazol-2-yl)-1-phenylethylidene]amino]-4-methoxybenzamide
N-[(Z)-[2-(1H-imidazol-2-yl)-1-phenylethylidene]amino]-4-methoxybenzamide
S-(4-hydroxy-1-oxononan-3-yl)cysteinylglycine
S-(4-hydroxy-1-oxononan-3-yl)cysteinylglycine
A dipeptide that is cysteinylglycine in which the thiol hydrogen has been replaced by a 4-hydroxy-1-oxononan-3-yl group.
[(E)-3-(Methylthio)acrylic acid](1R)-1beta,8abeta-dimethyl-6-oxo-7-isopropylidene-1,2,3,4,6,7,8,8a-octahydronaphthalene-2alpha-yl ester
[(E)-3-(Methylthio)acrylic acid](1R)-1beta,8abeta-dimethyl-6-oxo-7-isopropylidene-1,2,3,4,6,7,8,8a-octahydronaphthalene-2alpha-yl ester
Anti-4,5,8-trifluoro-6-methoxy-12,14,16-trimethyl(2.2)metacyclophane
Anti-4,5,8-trifluoro-6-methoxy-12,14,16-trimethyl(2.2)metacyclophane
Hypidone (hydrochloride)
Hypidone (hydrochloride)
Hypidone hydrochloride (YL0919) is an orally active antidepressant agent with dual activity as a highly seletive 5-HT uptake blocker and an effective 5-HT1A?receptor agonist (Ki=0.19 nM). Hypidone hydrochloride inhibits the uptake of [3H]-5-HT into rat cerebral cortical synaptosomes and HEK293 cells with IC50s of 1.78 nM and 1.93 nM, respectively. Hypidone hydrochloride shows remarkable antidepressant effects in animal models and has the poential for the investigation of depressive disorder[1].
6-[hydroxy(4-hydroxyphenyl)methyl]-1,5-dimethoxy-3-(sec-butyl)pyrazin-2-one
6-[hydroxy(4-hydroxyphenyl)methyl]-1,5-dimethoxy-3-(sec-butyl)pyrazin-2-one
3-[(4-hydroxyphenyl)methyl]-4-(2-methylpropyl)-5-(phenylmethylidene)furan-2-one
3-[(4-hydroxyphenyl)methyl]-4-(2-methylpropyl)-5-(phenylmethylidene)furan-2-one
{3,4,5-trihydroxy-6-[(2-methylpropanoyl)oxy]oxan-2-yl}methyl 2-methylbutanoate
{3,4,5-trihydroxy-6-[(2-methylpropanoyl)oxy]oxan-2-yl}methyl 2-methylbutanoate
11-(fluoromethyl)-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.1⁵,⁸.0¹,¹⁰.0²,⁸]heptadecane-9-carboxylic acid
11-(fluoromethyl)-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.1⁵,⁸.0¹,¹⁰.0²,⁸]heptadecane-9-carboxylic acid
3,4a,5-trimethyl-2-oxo-4h,5h,6h,7h,8h,8ah,9h,9ah-naphtho[2,3-b]furan-6-yl but-2-enethioate
3,4a,5-trimethyl-2-oxo-4h,5h,6h,7h,8h,8ah,9h,9ah-naphtho[2,3-b]furan-6-yl but-2-enethioate
2-{[(2-aminophenyl)(hydroxy)methylidene]amino}-n-[2-(1h-indol-3-yl)ethenyl]ethanimidic acid
2-{[(2-aminophenyl)(hydroxy)methylidene]amino}-n-[2-(1h-indol-3-yl)ethenyl]ethanimidic acid
11-hydroxy-10-{[2-(4-hydroxyphenyl)ethenyl]imino}-2,7-dimethyl-2,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-1(11),2,4(12),8-tetraen-2-ium
11-hydroxy-10-{[2-(4-hydroxyphenyl)ethenyl]imino}-2,7-dimethyl-2,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-1(11),2,4(12),8-tetraen-2-ium
(5e)-3-[(4-hydroxyphenyl)methyl]-4-(2-methylpropyl)-5-(phenylmethylidene)furan-2-one
(5e)-3-[(4-hydroxyphenyl)methyl]-4-(2-methylpropyl)-5-(phenylmethylidene)furan-2-one
(1r,2s,5r,8r,9s,10r,11s)-11-(fluoromethyl)-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.1⁵,⁸.0¹,¹⁰.0²,⁸]heptadecane-9-carboxylic acid
(1r,2s,5r,8r,9s,10r,11s)-11-(fluoromethyl)-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.1⁵,⁸.0¹,¹⁰.0²,⁸]heptadecane-9-carboxylic acid
2-{2-[2,3-bis(hydroxymethyl)cyclopent-1-en-1-yl]ethoxy}-6-(hydroxymethyl)oxane-3,4,5-triol
2-{2-[2,3-bis(hydroxymethyl)cyclopent-1-en-1-yl]ethoxy}-6-(hydroxymethyl)oxane-3,4,5-triol
[(2r,3s,4s,5r,6s)-3,4,5-trihydroxy-6-[(2-methylpropanoyl)oxy]oxan-2-yl]methyl (2r)-2-methylbutanoate
[(2r,3s,4s,5r,6s)-3,4,5-trihydroxy-6-[(2-methylpropanoyl)oxy]oxan-2-yl]methyl (2r)-2-methylbutanoate
(2r,3r,4r,5s,6r)-2-{2-[(3s)-2,3-bis(hydroxymethyl)cyclopent-1-en-1-yl]ethoxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(2r,3r,4r,5s,6r)-2-{2-[(3s)-2,3-bis(hydroxymethyl)cyclopent-1-en-1-yl]ethoxy}-6-(hydroxymethyl)oxane-3,4,5-triol
1,8a-dimethyl-6-oxo-7-(propan-2-ylidene)-2,3,4,8-tetrahydro-1h-naphthalen-2-yl 3-(methylsulfanyl)prop-2-enoate
1,8a-dimethyl-6-oxo-7-(propan-2-ylidene)-2,3,4,8-tetrahydro-1h-naphthalen-2-yl 3-(methylsulfanyl)prop-2-enoate
(4as,5r,6r,8ar,9ar)-3,4a,5-trimethyl-2-oxo-4h,5h,6h,7h,8h,8ah,9h,9ah-naphtho[2,3-b]furan-6-yl (2e)-but-2-enethioate
(4as,5r,6r,8ar,9ar)-3,4a,5-trimethyl-2-oxo-4h,5h,6h,7h,8h,8ah,9h,9ah-naphtho[2,3-b]furan-6-yl (2e)-but-2-enethioate
(5e)-4-methoxy-5-({4-methoxy-1h,1'h-[2,2'-bipyrrol]-5-yl}methylidene)-1'h-2,2'-bipyrrole
(5e)-4-methoxy-5-({4-methoxy-1h,1'h-[2,2'-bipyrrol]-5-yl}methylidene)-1'h-2,2'-bipyrrole
(1r,2r,8ar)-1,8a-dimethyl-6-oxo-7-(propan-2-ylidene)-2,3,4,8-tetrahydro-1h-naphthalen-2-yl (2z)-3-(methylsulfanyl)prop-2-enoate
(1r,2r,8ar)-1,8a-dimethyl-6-oxo-7-(propan-2-ylidene)-2,3,4,8-tetrahydro-1h-naphthalen-2-yl (2z)-3-(methylsulfanyl)prop-2-enoate
(1r,2r,7r,8ar)-1,8a-dimethyl-6-oxo-7-(prop-1-en-2-yl)-1,2,3,4,7,8-hexahydronaphthalen-2-yl (2e)-3-(methylsulfanyl)prop-2-enoate
(1r,2r,7r,8ar)-1,8a-dimethyl-6-oxo-7-(prop-1-en-2-yl)-1,2,3,4,7,8-hexahydronaphthalen-2-yl (2e)-3-(methylsulfanyl)prop-2-enoate
(1r,2r,7r,8ar)-1,8a-dimethyl-6-oxo-7-(prop-1-en-2-yl)-1,2,3,4,7,8-hexahydronaphthalen-2-yl 3-(methylsulfanyl)prop-2-enoate
(1r,2r,7r,8ar)-1,8a-dimethyl-6-oxo-7-(prop-1-en-2-yl)-1,2,3,4,7,8-hexahydronaphthalen-2-yl 3-(methylsulfanyl)prop-2-enoate
3-[(2r)-butan-2-yl]-6-[(r)-hydroxy(4-hydroxyphenyl)methyl]-1,5-dimethoxypyrazin-2-one
3-[(2r)-butan-2-yl]-6-[(r)-hydroxy(4-hydroxyphenyl)methyl]-1,5-dimethoxypyrazin-2-one
2-{[(2-aminophenyl)(hydroxy)methylidene]amino}-n-[(1e)-2-(1h-indol-3-yl)ethenyl]ethanimidic acid
2-{[(2-aminophenyl)(hydroxy)methylidene]amino}-n-[(1e)-2-(1h-indol-3-yl)ethenyl]ethanimidic acid
